scispace - formally typeset
D

Darshan P. Patel

Researcher at University of Utah

Publications -  59
Citations -  1144

Darshan P. Patel is an academic researcher from University of Utah. The author has contributed to research in topics: Infertility & Urinary bladder. The author has an hindex of 15, co-authored 54 publications receiving 774 citations. Previous affiliations of Darshan P. Patel include Drexel University & Huntsman Cancer Institute.

Papers
More filters
Journal ArticleDOI

No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019.

TL;DR: Severe acute respiratory syndrome–CoV-2 was not detected in the semen of patients recovering from CO VID-19 1 month after COVID-19 diagnosis and angiotensin-converting enzyme 2–mediated viral entry of SARS–Cov-2 into target host cells is unlikely to occur within the human testicle based on ACE2 and TMPRSS2 expression.
Journal ArticleDOI

Patient reported outcomes measures in neurogenic bladder and bowel: A systematic review of the current literature.

TL;DR: QoL in patients with multiple sclerosis, spinal cord injury, Parkinson's Disease, stroke, or spina bifida affected by bladder or bowel dysfunction, and the impact of specific bladder and bowel management on QoL are described.
Journal ArticleDOI

Patient Reported Bladder Related Symptoms and Quality of Life after Spinal Cord Injury with Different Bladder Management Strategies.

TL;DR: In individuals with spinal cord injury fewer bladder Symptoms were associated with an indwelling catheter and surgery, and worse bladder symptoms were noted in voiding individuals compared to those on clean intermittent catheterization, and Satisfaction with the urinary system was improved after surgery.
Journal ArticleDOI

Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score

TL;DR: A sharp decline in prostate cancer incidence began before release of the United States Preventative Services Task Force October 2011 draft and May 2012 final screening recommendation, and the greatest change occurred with incidence of low‐grade tumors, although there is concern that some high-grade tumors may now go undetected.